Clinical Trials on Salivary Gland Malignant Neoplasms in Netherlands

Total 488 results

Radboud University Medical Center
Ipsen

Terminated

Cabozantinib in Advanced Salivary Gland Cancer Patients (Cabo ASAP)

Salivary Gland Cancer

Netherlands
Radboud University Medical Center
Dutch Cancer Society

Recruiting

PSMA-PET Imaging Before and After ADT in Advanced SDC Patients (ADT-SCAN)

Salivary Gland Cancer | Salivary Duct Carcinoma

Netherlands
Radboud University Medical Center
Dutch Cancer Society

Completed

Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients (LUPSA)

Adenoid Cystic Carcinoma | Salivary Gland Cancer | Salivary Duct Carcinoma

Netherlands
Radboud University Medical Center
Adenoid Cystic Carcinoma Research Foundation

Completed

PSMA-PET Imaging for Advanced ACC/SDC

Adenoid Cystic Carcinoma | Salivary Gland Cancer | Salivary Duct Carcinoma

Netherlands
European Organisation for Research and Treatment...

Active, not recruiting

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Salivary Gland Cancer

Belgium, France, Netherlands, Italy, Hungary, Germany, Austria, Greece
Amsterdam UMC, location VUmc

Completed

Tumor Kinase Inhibitor Concentrations Measured by PET (PIKTURE)

Disseminated Malignant Neoplasm

Netherlands
Sanofi
Merck KGaA, Darmstadt, Germany

Completed

A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients

Neoplasm Malignant

Netherlands, France
Sanofi

Completed

Phase 1 Safety Testing of SAR405838

Neoplasm Malignant

United States, France, Netherlands
University Medical Center Groningen

Active, not recruiting

ImmunoPET With an Anti-CD8 Imaging Agent

Metastatic Cancer | Unresectable Malignant Neoplasm

Netherlands
University Medical Center Groningen

Recruiting

Virtual Bronchoscopic Navigation to Increase Diagnostic Yield in Patients With Pulmonary Nodules (NAVIGATOR)

Pulmonary Nodules, Solitary

Netherlands
Leiden University Medical Center

Completed

Shorter Scalp Cooling Time in Paclitaxel (COP)

Breast Cancer | Ovarian Cancer | Neoplasm Malignant

Netherlands
The Netherlands Cancer Institute
Pfizer

Unknown

Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Netherlands
Philips Healthcare
Philips Electronics Nederland B.V. acting through Philips CTO organization

Completed

Optical Detection of Peripheral Nerve Bundles During Surgery (NerveSpect)

Malignant Lymphoma of Lymph Nodes of Inguinal Region | Malignant Lymphoma of Lymph Nodes of Axillary | Malignant Lymphoma of Lymph Nodes of the Cervix | Carcinoma of Parotid Gland | Colon Rectal Cancer Tubulovillous Adenocarcinoma | Tumor of Soft Tissue of Head, Face and Neck

Netherlands
GE Healthcare

Recruiting

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Oncology | Malignant Solid Tumor

Netherlands
Leiden University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

A Mouth Education Program for Dry Mouth (MEP)

Frailty | Xerostomia | End of Life | Dry Mouth

Netherlands
Radboud University Medical Center

Terminated

Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

Malignant Ascites | Malignant Pleural Effusion

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Phase II Dutasteride in Combination With CAB vs CAB in SDC (DUCT)

Salivary Duct Carcinoma

Netherlands
UMC Utrecht

Completed

Quality of Life After Surgery for Pancreatic Carcinoma

Patients Suspected for a Pancreatic (Pre-)Malignancy

Netherlands
Radboud University Medical Center

Completed

The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules (Coffee Break)

Pulmonary Nodule, Solitary

Netherlands
Maastricht University Medical Center

Completed

Local Pilocarpine for Relieving Dry Mouth

Patients of Advanced Age (≥ 70 Years) With a Clinical Diagnosis of Chronic Dry Mouth

Netherlands
Cephalon

Completed

Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy

Malignancy

Netherlands
Amsterdam UMC, location VUmc

Completed

Effect of Aminobiphosphonates and Statins on Circulating Vgamma9Vdelta2-T Cells

Bone Metastases of a Malignant Tumor

Netherlands
Koen Rovers
Hoffmann-La Roche; Comprehensive Cancer Centre The Netherlands; Dutch Cancer...

Recruiting

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases (CAIRO6)

Colorectal Cancer | Peritoneal Neoplasms | Colorectal Neoplasm | Peritoneal Carcinomatosis | Colorectal Carcinoma | Peritoneal Cancer | Peritoneal Metastases | Colorectal Adenocarcinoma | Colorectal Neoplasms Malignant | Peritoneal Neoplasm Malignant Secondary Carcinomatosis | Peritoneal Neoplasm Malignant...

Netherlands, Belgium
Sanofi

Completed

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Neoplasm Malignant

Netherlands, Belgium, Spain, Italy, United Kingdom
Merck Sharp & Dohme LLC

Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Cervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditions

Canada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
The Netherlands Cancer Institute
Pfizer

Completed

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma (N08CPA)

Malignant Pleural Mesothelioma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Completed

Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma (INITIATE)

Malignant Pleural Mesothelioma

Netherlands
Erasmus Medical Center

Recruiting

Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma (INTERACT MESO)

Peritoneal Malignant Mesothelioma

Netherlands
Erasmus Medical Center

Completed

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma (PMR-MM-002)

Malignant (Pleural) Mesothelioma

Netherlands
Erasmus Medical Center

Completed

Dendritic Cell-based Immunotherapy in Mesothelioma

Malignant Pleural Mesothelioma

Netherlands
Molecular Partners AG

Terminated

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Advanced Malignant Solid Tumor

Netherlands, France
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Confocal Laser Endomicroscopy in Pleural Malignancies

Pleural Diseases | Thymoma | Pleural Malignant Mesothelioma

Netherlands
University Hospital, Ghent
Merck Sharp & Dohme LLC

Completed

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. (MesoMab)

Cancer

Belgium, Netherlands
European Organisation for Research and Treatment...

Active, not recruiting

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Malignant Pleural Mesothelioma

Belgium, Netherlands
Leiden University Medical Center
Philips Healthcare; European Commission

Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors (A-IMAGIO)

Hepatocellular Carcinoma | Liver Metastases | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
Amsterdam UMC, location VUmc

Terminated

Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities

Advanced or Metastatic Solid Malignancy

Netherlands
The Netherlands Cancer Institute

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma

Netherlands
UMC Utrecht

Recruiting

The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA) (COIMBRA)

Brain Metastases, Adult | Brain Neoplasms, Adult, Malignant

Netherlands
The Netherlands Cancer Institute
4SC

Active, not recruiting

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI)

Malignant Melanoma Stage III

Netherlands
A.J.M. van den Eertwegh
Idera Pharmaceuticals, Inc.

Recruiting

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (INTRIM)

Malignant Melanoma

Netherlands
Princess Maxima Center for Pediatric Oncology

Recruiting

International Leukemia Target Board (iLTB)

Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy

Netherlands
Amsterdam UMC, location VUmc
Novartis; Borstkanker Onderzoek Groep

Unknown

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Metastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Tapestry: Addition of TGF-β and PDL-1 Inhibition to Definitive Chemoradiation in Esophageal Squamous Cell Carcinoma (TAPESTRY)

Neoplasm, Esophageal | Neoplasm, Esophagus | Malignant Esophagus Tumor

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN-neo)

Malignant Melanoma Stage III

Austria, Netherlands, Australia, Sweden
European Organisation for Research and Treatment...

Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Malignant Mesothelioma

Italy, Netherlands
Radboud University Medical Center

Terminated

Screening for Familial Gastric Cancer in First Degree Relatives (FamGaCan)

Malignant Neoplasm of Stomach | Carcinoma, Diffuse Type | Intestinal Type Adenocarcinoma of Stomach | Relative (Related Person)

Netherlands
VieCuri Medical Centre

Completed

Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment

Colorectal Cancer | Surgery | Colorectal Neoplasms Malignant

Netherlands
Amphia Hospital

Recruiting

Obstructive Colon Cancer, a Bridge to Surgery in Right Sided Obstructive Colon Cancer (OCCBRIGHT)

Colonic Neoplasms Malignant

Netherlands
Sanofi

Completed

Effect of Cabazitaxel on the QTc Interval in Cancer Patients (QT-Cab)

Neoplasms, Malignant

United States, Belgium, Denmark, Netherlands, Sweden
Bayer

Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)

United States, Sweden, Netherlands, United Kingdom, Finland

Clinical Trials on Salivary Gland Malignant Neoplasms in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations